Smith Group Asset Management
ACHV icon

Smith Group Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Smith Group Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-73
Closed -$1.89M – 413
2014
Q1 		$1.89M Sell
73
-1
-1% -$24.6K 0.07% 162
2013
Q4 		$1.35M Buy
+74
New +$1.3M 0.05% 171
2013
Q3 		– Sell
-30
Closed -$648K – 410
2013
Q2 		$648K Buy
+30
New +$671K 0.03% 196

Other funds holding ACHV

Great Point Partners
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Abingworth
Abingworth London, United Kingdom $304M AUM 95.02% 1-Year Est. Return
Visium Asset Management
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Smith Group Asset Management's ACHV Position: Q2 2014 in Review

Smith Group Asset Management sold out of Achieve Life Sciences (ACHV) in Q2 2014, closing a stake of 73 shares — an estimated $1.89M sold.

Smith Group Asset Management first reported a position in ACHV in Q2 2013 and held it in 3 quarters. The position peaked at $1.89M in Q1 2014. 63 funds tracked by Wall St. Rank hold ACHV as of Q2 2014.

  • Smith Group Asset Management reported no remaining Achieve Life Sciences position as of Q2 2014 after selling out during the quarter.
  • Smith Group Asset Management sold 73 Achieve Life Sciences shares in Q2 2014, an estimated $1.89M.
  • Smith Group Asset Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 3 quarters.
  • Smith Group Asset Management's Achieve Life Sciences position peaked at $1.89M in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2014.

Based on Smith Group Asset Management's 13F filing for Q2 2014, filed 23 Jul 2014.